SL 535
Pill imprint SL 535 has been identified as Guaifenesin 600 MG.
Guaifenesin is used in the treatment of cough; bronchitis; fibromyalgia and belongs to the drug class expectorants. Risk cannot be ruled out during pregnancy.
Guaifenesin 600 MG is not subject to the Controlled Substances Act.
See also related documents.
Guaifenesin Images
- Imprint:
-
SL 535
- Strength:
- 600 MG
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Expectorants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sidmak
Advertisement
More GUAIFENESIN resources
- Guaifenesin
- Guaifenesin Granules (Wolters Kluwer)
- Guaifenesin Immediate-Release Capsules (Wolters Kluwer)
- Guaifenesin Liquid (Wolters Kluwer)
- Guaifenesin Sustained-Release Tablets (Wolters Kluwer)
- Robitussin Maximum Strength Liquid (Wolters Kluwer)
- guaifenesin (Cerner Multum)
- Allfen (Micromedex) - Includes Dosage Information
- Antitussin (Micromedex) - Includes Dosage Information
- Broncho-Grippex Expectorant (Micromedex) - Includes Dosage Information
- Diabetic Siltussin DAS-Na (Micromedex) - Includes Dosage Information
- Robitussin Extra Strength (Micromedex) - Includes Dosage Information
- guaifenesin (Micromedex) - Includes Dosage Information
- Guaifenesin (AHFS DI)
- Guaifenesin NR (FDA)
- Guaifenesin Tablets (FDA)
- Mucinex Maximum Strength (FDA)
- Guaifenesin(Glyceryl Guaiacolate) (Wolters Kluwer)
Search Again
